Stopping HIV fusion with enfuvirtide: the first step to extracellular HAART.
Moyle
Graeme
G
HIV Research Department, Chelsea and Westminster Hospital, London, UK. gm@moyleg.demon.co.uk
D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D024882:Drug Resistance, Viral; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000008:administration & dosage / Q000494:pharmacology*; D023581:HIV Fusion Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D010446:Peptide Fragments / Q000008:administration & dosage / Q000494:pharmacology*
D015700:HIV Envelope Protein gp41; D023581:HIV Fusion Inhibitors; D010446:Peptide Fragments; D000077560:Enfuvirtide